Month: September 2019 | Pascal Biosciences

23Sep 2019

Pascal Biosciences Discovers Cannabinoids Activate the Major Histocompatibility Complex to Aid Cancer Treatment

Sep 23, 2019
Uncategorized

VANCOUVER, BRITISH COLUMBIA, and SEATTLE, WASHINGTON, Sept 23, 2019 –Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today revealed the mechanism whereby cannabinoids may directly aid in cancer treatment. Specific cannabinoids identified by Pascal scientists enhance the immunogenicity of tumor…

11Sep 2019

Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceuticals Summit

Sep 11, 2019
Press Releases

VANCOUVER, BRITISH COLUMBIA, and SEATTLE, WASHINGTON, Sept 11, 2019 –Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”). Pascal announces that Dr. Patrick Gray, CEO, will present an update today on the Company’s lead cannabinoid-based drug candidate, PAS-403, at the Second…